Biologically active taxane analogs and methods of treatment by oral administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9802951
SERIAL NO

13950316

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAPESTRY PHARMACEUTICALS INC4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Emerson, David Lloyd Longmont, US 7 11
Kurman, Michael Upper Saddle River, US 15 28
Marshall, John Washington, US 331 5430
McChesney, James D Etta, US 72 324
Modiano, Manuel R Tucson, US 6 1
Tapolsky, Gilles H Louisville, US 31 749

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00